{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T05:58:24Z","timestamp":1769839104719,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["NCT00382291"],"award-info":[{"award-number":["NCT00382291"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jpsychires.2015.10.006","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T15:33:05Z","timestamp":1445527985000},"page":"140-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial"],"prefix":"10.1016","volume":"71","author":[{"given":"Adam M.","family":"Reid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph P.H.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya K.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew G.","family":"Guzick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Storch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary R.","family":"Geffken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Bussing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2015.10.006_bib1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.janxdis.2011.04.004","article-title":"Objective sleep patterns and severity of symptoms in pediatric obsessive compulsive disorder: a pilot investigation","volume":"25","author":"Alfano","year":"2011","journal-title":"J.\u00a0Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-0327(99)00092-0","article-title":"Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability","volume":"58","author":"Anderson","year":"2000","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1586\/ern.12.160","article-title":"Augmentation strategies in obsessive-compulsive disorder","volume":"13","author":"Arumugham","year":"2013","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00004714-199106000-00004","article-title":"High-dose fluoxetine: efficacy and activating-sedating effects in agitated and retarded depression","volume":"11","author":"Beasley","year":"1991","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib6","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/mp.2009.50","article-title":"Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder","volume":"15","author":"Bloch","year":"2010","journal-title":"Mole Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib7","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.biopsych.2012.10.012","article-title":"Chronic antidepressant treatment impairs the acquisition of fear extinction","volume":"73","author":"Burghardt","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.psychres.2012.09.019","article-title":"Psychometric properties of the Treatment-Emergent Activation and Suicidality Assessment Profile (TEASAP) in youth with OCD","volume":"205","author":"Bussing","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib9","article-title":"A\u00a0pilot study of actigraphy as an objective measure of SSRI activation symptoms: results from a randomized placebo controlled psychopharmacological treatment study","volume":"225","author":"Bussing","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0447.2006.00974.x","article-title":"Why people do not take their psychotropic drugs as prescribed: results of the 2000 National Psychiatric Morbidity Survey","volume":"116","author":"Cooper","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib11","doi-asserted-by":"crossref","first-page":"e04","DOI":"10.4088\/JCP.9058se1c.04gry","article-title":"Major depressive disorder treatment guidelines in America and Europe","volume":"71","author":"Davidson","year":"2010","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1176\/appi.ajp.162.1.151","article-title":"Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder","volume":"162","author":"Foa","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2015.02.009","article-title":"Cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: empirical review and clinical recommendations","volume":"227","author":"Franklin","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib14","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s10802-011-9494-6","article-title":"The Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity for use among 5 to 8 year olds with obsessive-compulsive disorder","volume":"39","author":"Freeman","year":"2011","journal-title":"J.\u00a0Abnorm Child. Psychol."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaac.2011.09.019","article-title":"Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder","volume":"51","author":"Geller","year":"2012","journal-title":"J.\u00a0Am. Acad. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/0269881198012003041","article-title":"Selective serotonin reuptake inhibitors in the treatment of affective disorders\u2014III. Tolerability, safety and pharmacoeconomics","author":"Goldstein","year":"1998","journal-title":"J.\u00a0Psychopharmacol"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00004714-198710000-00007","article-title":"An open trial of fluoxetine in the treatment of panic attacks","volume":"7","author":"Gorman","year":"1987","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2015.01.015","article-title":"The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: views based on a systematic review and meta-analysis","volume":"227","author":"Ivarsson","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10879-012-9210-z","article-title":"First-line treatment for pediatric obsessive-compulsive disorder","volume":"42","author":"Jordan","year":"2012","journal-title":"J\u00a0Contemp Psychother"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/jclp.21964","article-title":"It's the destination and it's the journey: using multilevel modeling to assess patterns of change in psychotherapy","volume":"69","author":"Kahn","year":"2013","journal-title":"J.\u00a0Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib22","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","article-title":"Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data","volume":"36","author":"Kaufman","year":"1997","journal-title":"J.\u00a0Am. Acad. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cpr.2007.04.003","article-title":"Clinical predictors of response to cognitive-behavioral therapy for obsessive-compulsive disorder","volume":"28","author":"Keeley","year":"2008","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.31887\/DCNS.2010.12.2\/mkellner","article-title":"Drug treatment of obsessive-compulsive disorder","volume":"12","author":"Kellner","year":"2010","journal-title":"Dialogue Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib25","first-page":"5","article-title":"American Psychiatric Association: practice guideline for the treatment of patients with obsessive-compulsive disorder","volume":"164","author":"Koran","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib26","series-title":"Introducing Multilevel Modeling","author":"Kreft","year":"1998"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib27","unstructured":"Labeling change request letter for antidepressant medication. US Food and Drug Administration Web site. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/InformationbyDrugClass\/ucm096352.htm. Published October 15, 2004. Accessed October 10, 2014."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib28","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.brat.2011.06.001","article-title":"The role of treatment expectancy in youth receiving exposure-based CBT for obsessive compulsive disorder","volume":"49","author":"Lewin","year":"2011","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1027\/1614-2241.1.3.86","article-title":"Sufficient sample sizes for multilevel modeling","volume":"49","author":"Maas","year":"2005","journal-title":"Methodology"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib30","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.psych.58.110405.085542","article-title":"Mediation analysis","volume":"58","author":"Mackinnon","year":"2007","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib31","series-title":"OCD in Children and Adolescents: a Cognitive-Behavioral Treatment Manual","author":"March","year":"1998"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib32","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jama.292.7.807","article-title":"Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: treatment for Adolescents with Depression Study (TADS) randomized controlled trial","volume":"292","author":"March","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/cap.2010.0063","article-title":"Psychometric properties of the Children's Depression Rating Scale\u2013Revised in adolescents","volume":"20","author":"Mayes","year":"2010","journal-title":"J.\u00a0Child. Adol Psychop"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/09540260801889211","article-title":"SSRI adverse events: how to monitor and manage","volume":"20","author":"Murphy","year":"2008","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib35","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1001\/jama.292.16.1969","article-title":"Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial","volume":"292","author":"Pediatric OCD Treatment Study (POTS) Team","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1359786806064314","article-title":"Enhancing the efficacy of antidepressants with psychotherapy","volume":"20","author":"Petersen","year":"2006","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib37","first-page":"100","article-title":"The jitteriness syndrome in panic disorder patients treated with antidepressants","volume":"49","author":"Pohl","year":"1988","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib38","series-title":"Children's Depression Rating Scale, Revised (CDRS-R)","author":"Poznanski","year":"1996"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/cap.1990.1.193","article-title":"Behavioral side effects of fluoxetine in children and adolescents","volume":"1","author":"Riddle","year":"1990","journal-title":"J.\u00a0Child. Adol Psychop"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib40","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00004583-200102000-00017","article-title":"Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial","volume":"40","author":"Riddle","year":"2001","journal-title":"J.\u00a0Am. Acad. Child. Adolesc. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.jpsychires.2015.10.006_bib41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/cap.2006.16.159","article-title":"Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents","volume":"16","author":"Safer","year":"2006","journal-title":"J.\u00a0Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.janxdis.2013.10.007","article-title":"Differential efficacy of cognitive-behavioral therapy and pharmacological treatments for pediatric obsessive-compulsive disorder: a meta-analysis","volume":"28","author":"S\u00e1nchez-meca","year":"2014","journal-title":"J.\u00a0Anxiety Disord."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib43","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00004583-199706000-00023","article-title":"Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity","volume":"36","author":"Scahill","year":"1997","journal-title":"J.\u00a0Am. Acad. Child. Adolesc. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2015.10.006_bib44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00702-009-0330-x","article-title":"Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study","volume":"117","author":"Schirman","year":"2010","journal-title":"J.\u00a0neural Transm."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1192\/bjp.bp.107.048371","article-title":"Antidepressant-induced jitteriness\/anxiety syndrome: systematic review","volume":"194","author":"Sinclair","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib46","series-title":"Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence","author":"Singer","year":"2003"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib47","series-title":"Multilevel Analysis: an Introduction to Basic and Advanced Multilevel Modeling","author":"Snijders","year":"1999"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.psychres.2004.06.009","article-title":"Psychometric evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale","volume":"129","author":"Storch","year":"2004","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib49","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.brat.2013.09.007","article-title":"Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder","volume":"51","author":"Storch","year":"2013","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib50","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/10503300802641444","article-title":"Multilevel modeling of longitudinal data for psychotherapy researchers: I. The basics","volume":"19","author":"Tasca","year":"2009","journal-title":"Psychother. Res."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib51","series-title":"Psychological Treatment of Obsessive-Compulsive Disorder: Fundamentals and Beyond","first-page":"9","article-title":"Cognitive-behavioral models of obsessive-compulsive disorder","author":"Taylor","year":"2007"},{"key":"10.1016\/j.jpsychires.2015.10.006_bib52","first-page":"62","article-title":"Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis","volume":"18","author":"Usala","year":"2008","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib53","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1056\/NEJMoa0804633","article-title":"Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety","volume":"359","author":"Walkup","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2015.10.006_bib56","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000118801","article-title":"Imipramine-induced jitteriness and decreased serum iron levels","volume":"25","author":"Yeragani","year":"1992","journal-title":"Neuropsychobiology"}],"updated-by":[{"DOI":"10.1016\/j.jpsychires.2016.01.005","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000}}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395615002952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395615002952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:10:05Z","timestamp":1758366605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395615002952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":52,"alternative-id":["S0022395615002952"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2015.10.006","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2015.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}